Breast Cancer Research and Treatment

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Tumor Microenvironment".

Deadline for manuscript submissions: 31 December 2025 | Viewed by 147

Special Issue Editor


E-Mail Website
Guest Editor
Center for Cancer Research (CCR), National Cancer Institute (NCI), Bethesda, MD 20892, USA
Interests: cancer genomics; genetics; epidemiology; bioinformatics

Special Issue Information

Dear Colleagues,

Breast cancer is classified into four molecular subtypes: luminal A, luminal B, triple-negative breast cancer (TNBC), and human epidermal growth factor receptor type 2 (HER2)-positive. The tumor microenvironment plays a critical role in modulating the aggressiveness and differentiation of malignant cells. Advances in single-cell genomics have transformed our ability to analyze the cellular, transcriptional, and epigenetic heterogeneity of human tumors with unprecedented resolution. This Special Issue will highlight recent progress in our understanding of the tumor and immune microenvironments, as well as identifying relevant biomarkers and therapeutic targets, paving the way for breast cancer to become a curable disease.

Dr. Huaitian Liu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • breast cancer
  • tumor microenvironment
  • immune microenvironment
  • intratumoral heterogeneity
  • immunotherapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop